MLYS logo

Mineralys Therapeutics (MLYS) Company Overview

Profile

Full Name:

Mineralys Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

February 10, 2023

Indexes:

Not included

Description:

Mineralys Therapeutics is a biopharmaceutical company focused on developing innovative treatments for hypertension and related conditions. They aim to improve patient outcomes by targeting mineralocorticoid receptor pathways, offering new therapies that address unmet medical needs in cardiovascular health.

Events Calendar

Earnings

Next earnings date:

Feb 12, 2025

Recent quarterly earnings:

Nov 11, 2024

Recent annual earnings:

Mar 21, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Nov 12, 24 HC Wainwright & Co.
Buy
Oct 31, 24 HC Wainwright & Co.
Buy
Aug 15, 24 HC Wainwright & Co.
Buy
Jul 10, 24 HC Wainwright & Co.
Buy
Apr 2, 24 Goldman Sachs
Buy
Aug 8, 23 Credit Suisse
Outperform
May 16, 23 Credit Suisse
Outperform
Mar 16, 23 Credit Suisse
Outperform
Mar 7, 23 Wells Fargo
Overweight
Mar 7, 23 Stifel
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Mineralys Therapeutics?
  • Does Mineralys Therapeutics pay dividends?
  • What sector is Mineralys Therapeutics in?
  • What industry is Mineralys Therapeutics in?
  • What country is Mineralys Therapeutics based in?
  • When did Mineralys Therapeutics go public?
  • Is Mineralys Therapeutics in the S&P 500?
  • Is Mineralys Therapeutics in the NASDAQ 100?
  • Is Mineralys Therapeutics in the Dow Jones?
  • When was Mineralys Therapeutics's last earnings report?
  • When does Mineralys Therapeutics report earnings?
  • Should I buy Mineralys Therapeutics stock now?

What is the ticker symbol for Mineralys Therapeutics?

The ticker symbol for Mineralys Therapeutics is NASDAQ:MLYS

Does Mineralys Therapeutics pay dividends?

No, Mineralys Therapeutics does not pay dividends

What sector is Mineralys Therapeutics in?

Mineralys Therapeutics is in the Healthcare sector

What industry is Mineralys Therapeutics in?

Mineralys Therapeutics is in the Biotechnology industry

What country is Mineralys Therapeutics based in?

Mineralys Therapeutics is headquartered in United States

When did Mineralys Therapeutics go public?

Mineralys Therapeutics's initial public offering (IPO) was on February 10, 2023

Is Mineralys Therapeutics in the S&P 500?

No, Mineralys Therapeutics is not included in the S&P 500 index

Is Mineralys Therapeutics in the NASDAQ 100?

No, Mineralys Therapeutics is not included in the NASDAQ 100 index

Is Mineralys Therapeutics in the Dow Jones?

No, Mineralys Therapeutics is not included in the Dow Jones index

When was Mineralys Therapeutics's last earnings report?

Mineralys Therapeutics's most recent earnings report was on Nov 11, 2024

When does Mineralys Therapeutics report earnings?

The next expected earnings date for Mineralys Therapeutics is Feb 12, 2025

Should I buy Mineralys Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions